LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.18 | 84.90 | 4098 | 6963 | 0.5885 | 0.8400 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.18 | 84.90 | 4111 | 6963 | 0.5904 | 0.8409 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.88 | 84.90 | 701 | 7291 | 0.0961 | 0.3890 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.88 | 84.90 | 4877 | 7291 | 0.6688 | 0.8786 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.88 | 84.90 | 4273 | 7291 | 0.5860 | 0.8404 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.88 | 84.90 | 4286 | 7291 | 0.5878 | 0.8412 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.59 | 84.90 | 698 | 7641 | 0.0913 | 0.3834 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.59 | 84.90 | 5050 | 7641 | 0.6608 | 0.8764 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.59 | 84.90 | 4405 | 7641 | 0.5764 | 0.8373 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.59 | 84.90 | 4416 | 7641 | 0.5779 | 0.8380 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.29 | 84.90 | 773 | 7934 | 0.0974 | 0.4013 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.29 | 84.90 | 5228 | 7934 | 0.6589 | 0.8765 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.29 | 84.90 | 4524 | 7934 | 0.5702 | 0.8355 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.29 | 84.90 | 4537 | 7934 | 0.5718 | 0.8363 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.99 | 84.90 | 824 | 8212 | 0.1003 | 0.4114 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.99 | 84.90 | 5402 | 8212 | 0.6578 | 0.8769 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.99 | 84.90 | 4699 | 8212 | 0.5722 | 0.8377 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.99 | 84.90 | 4714 | 8212 | 0.5740 | 0.8386 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.70 | 84.90 | 793 | 8484 | 0.0935 | 0.3998 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.70 | 84.90 | 5563 | 8484 | 0.6557 | 0.8769 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.70 | 84.90 | 4797 | 8484 | 0.5654 | 0.8355 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.70 | 84.90 | 4813 | 8484 | 0.5673 | 0.8364 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.41 | 84.90 | 849 | 8766 | 0.0968 | 0.4108 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.41 | 84.90 | 5759 | 8766 | 0.6569 | 0.8783 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.41 | 84.90 | 4886 | 8766 | 0.5574 | 0.8327 | MN20160318_Q02 | L04 |